The Department of Health (DOH) confirms that around 200,000 to 300,000 bottles of Tenofovir-Lamivudine-Dolutegravir (TLD), an antiretroviral (ARV) medication for the treatment of human immunodeficiency virus (HIV), have arrived, following reports of shortages. In an interview with __The Manila Times_ on July 8, 2026, DOH Undersecretary Albert Domingo said they were now awaiting quality inspection and eyeing a rollout by July 10 or early next week.